Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2017

01-08-2017 | Capsule Commentary

Capsule Commentary on Blumenthal et al., Using a Self-Reported Global Health Measure to Identify Patients at High Risk for Future Healthcare Utilization

Authors: Joel Papak, MD, Joseph Chiovaro, MD

Published in: Journal of General Internal Medicine | Issue 8/2017

Login to get access

Excerpt

Understanding which patients are at high risk for future emergency department (ED) visits and hospitalization has long been a goal of both healthcare systems and practicing clinicians. Identification of the highest-risk cohort, in particular, has been a target of interest, as these patients account for a disproportionate amount of healthcare expenditure. Efforts do to this have largely focused on the use of administrative data, though more recent studies suggest the addition of patient-reported outcome measures (PROMs) may better capture changes in health status. …
Literature
1.
Blumenthal KJ, Chang Y, Ferris TG, et al. Using a Self-Reported Global Health Measure to Identify Patients at High Risk for Future Healthcare Utilization. J Gen Intern Med. doi:10.​1007/​s11606-017-4041-y
2.
Fowles JB, Weiner JP, Knutson D, Fowler E, Tucker AM, Ireland M. Taking health status into account when setting capitation rates: a comparison of risk-adjustment methods. JAMA. 1996;276(16):1316–1321.CrossRefPubMed
3.
4.
5.
Metadata
Title
Capsule Commentary on Blumenthal et al., Using a Self-Reported Global Health Measure to Identify Patients at High Risk for Future Healthcare Utilization
Authors
Joel Papak, MD
Joseph Chiovaro, MD
Publication date
01-08-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4076-0

Other articles of this Issue 8/2017

Journal of General Internal Medicine 8/2017 Go to the issue

Review Paper

A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence

Original Research

Unintended Pregnancy and Contraceptive Use Among Women Veterans: The ECUUN Study

Original Research

Using a Self-Reported Global Health Measure to Identify Patients at High Risk for Future Healthcare Utilization

Capsule Commentary

Capsule Commentary on Borrero et al., Unintended Pregnancy and Contraceptive Use among Women Veterans: The ECUUN Study

Editorial

Controlling Hypertension: We Have the Tools—We Just Need to Use Them

Original Research

Engaging Stakeholders to Inform Clinical Practice Guidelines That Address Multiple Chronic Conditions
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits